Skip to main content
Caplight Logo









Remedy Robotics

Remedy Robotics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.remedyrobotics.com/

Last Round

Series B

Oct 6, 2025

Total Funding Raised

$70M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Remedy Robotics is a medical technology company developing an AI-enabled, remotely-operated endovascular robotic system for cardiovascular care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Medical Imaging

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

surgical roboticsteleroboticsneurointerventional surgeryremote surgeryrobotic surgerymedical roboticsendovascular interventionstroke interventiontelemedicinephysical AIsurgical navigationcomputer visionmedical devicerobotic platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remedy Robotics Comparables

Compare Remedy Robotics with similar companies based on industry and business-model similarity.

Remedy Robotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
XCath
92%
Navigantis
90%
Nanoflex Robotics
87%

Remedy Robotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 6, 2025

Key People

Founding team and executive leadership

Jake Sganga

Cofounder and CTO

Founding Team

Janine Yoong

COO

Executive Team

Remedy Robotics Investors

Notable investors and investment history

Remedy Robotics investors
InvestorRounds
Pathbreaker VenturesSeries A
Build CollectiveSeries A, Series B
KdT VenturesSeries A, Series B
Blackbird VenturesSeries A, Series B
Divergent CapitalSeed, Series B
DCVC (Data Collective)Series A, Seed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2026

    Grew 32% QoQ, from 19 to 25 employees.

  • Aug 21, 2026

    Monthly visitors grew 41% MoM, reaching 2.9K.

Remedy Robotics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remedy Robotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remedy Robotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range22
Year Founded2020
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?